Last 12 months
Inside the activity.
0 purchase rows · 153 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 25 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 14 |
| Feb 2026 | 0 | 24 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 23 |
| Jun 2026 | 0 | 20 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2020 Filed May 21, 2020 20:18 UTC |
Sinha UmaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 3,022 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000899243-20-013835 · doc4.xml · derivative · entry 5 Sinha Uma · CIK 0001742587 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,022 Underlying: Common Stock · 3,022 shares Expires 2029-09-30 F2 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:18 UTC |
Sinha UmaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,765 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0000899243-20-013835 · doc4.xml · derivative · entry 4 Sinha Uma · CIK 0001742587 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,765 Underlying: Common Stock · 49,765 shares Expires 2029-07-14 F2 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. F4 · derivative.exercise_date: 25,134 shares subject to the stock option were vested and exercisable as of the date of acquisition, 1,571 shares shall vest and become exercisable on June 1, 2020, and 23,060 shares shall vest and become exercisable in monthly installments over the next 15 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:18 UTC |
Sinha UmaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,361 | $0.00 Strike: $0.16 | $0.00 |
DisclosureSEC source: 0000899243-20-013835 · doc4.xml · derivative · entry 3 Sinha Uma · CIK 0001742587 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,361 Underlying: Common Stock · 49,361 shares Expires 2029-05-23 F2 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. F3 · derivative.exercise_date: 24,930 shares subject to the stock option were vested and exercisable as of the date of acquisition, 1,558 shares shall vest and become exercisable on June 1, 2020, and 22,873 shares shall vest and become exercisable in monthly installments over the next 15 months thereafter, in each case so long as the Reporting Person continues to have a service relationship with the Issuer or a Subsidiary on each such date. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:18 UTC |
Sinha UmaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,366 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0000899243-20-013835 · doc4.xml · derivative · entry 2 Sinha Uma · CIK 0001742587 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,366 Underlying: Common Stock · 5,366 shares Expires 2027-11-15 F2 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:18 UTC |
Sinha UmaChief Scientific Officer
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-013835 · doc4.xml · nonDerivative · entry 1 Sinha Uma · CIK 0001742587 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,523 F1 · kind: The shares were acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer (each, a "Subsidiary" and collectively, the "Subsidiaries"). Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:06 UTC |
MCCORMICK FRANKChairman of Oncology
|
GrantStock Option (Right to Buy) · Derivative | 10,549 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0000899243-20-013832 · doc4.xml · derivative · entry 2 MCCORMICK FRANK · CIK 0001257809 · Chairman of Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,549 Underlying: Common Stock · 10,549 shares Expires 2029-09-17 F2 · kind: The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:06 UTC |
MCCORMICK FRANKChairman of Oncology
|
GrantCommon Stock | 39,042 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-013832 · doc4.xml · nonDerivative · entry 1 MCCORMICK FRANK · CIK 0001257809 · Chairman of Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300,568 F1 · kind: The shares were acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer (each, a "Subsidiary" and collectively, the "Subsidiaries"). Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:26 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 5,706 | $30.49 | $173,959.39 |
DisclosureSEC source: 0000899243-20-012195 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,916 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $30.09 to $31.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:28 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 1,460 | $30.47 | $44,493.35 |
DisclosureSEC source: 0000899243-20-012196 · doc4.xml · nonDerivative · entry 1 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,362 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $30.13 to $30.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:21 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 34,834 | $31.23 | $1,088,012.12 |
DisclosureSEC source: 0000899243-20-012192 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,405,372 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $31.12 to $31.55 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:21 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 44,766 | $30.86 | $1,381,469.81 |
DisclosureSEC source: 0000899243-20-012192 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,440,206 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $30.12 to $31.115 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| May 04, 2020 Filed May 5, 2020 10:15 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 1,494 | $30.00 | $44,827.17 |
DisclosureSEC source: 0000899243-20-011989 · doc4.xml · nonDerivative · entry 3 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,622 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.02 per share. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:05 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 33,974 | $29.77 | $1,011,494.31 |
DisclosureSEC source: 0000899243-20-012046 · doc4.xml · nonDerivative · entry 4 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,484,972 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F6 · price: Represents the weighted average sale price of the shares sold from $29.49 to $30.14 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:05 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 5,706 | $29.13 | $166,190.67 |
DisclosureSEC source: 0000899243-20-012046 · doc4.xml · nonDerivative · entry 3 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,518,946 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F5 · price: Represents the weighted average sale price of the shares sold from $28.48 to $29.47 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| May 04, 2020 Filed May 5, 2020 10:13 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 1,320 | $30.01 | $39,613.33 |
DisclosureSEC source: 0000899243-20-011988 · doc4.xml · nonDerivative · entry 3 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,822 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $30.00 to $30.06 per share. Read SEC document |
| May 01, 2020 Filed May 5, 2020 10:15 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 1,200 | $29.83 | $35,794.56 |
DisclosureSEC source: 0000899243-20-011989 · doc4.xml · nonDerivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,116 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F3 · price: Represents the weighted average sale price of the shares sold from $29.71 to $30.14 per share. Read SEC document |
| May 01, 2020 Filed May 5, 2020 10:15 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 6,000 | $29.11 | $174,679.80 |
DisclosureSEC source: 0000899243-20-011989 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,316 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $28.71 to $29.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:05 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 4,098 | $29.78 | $122,054.83 |
DisclosureSEC source: 0000899243-20-012046 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,524,652 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $29.62 to $30.14 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:05 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 36,622 | $29.06 | $1,064,345.19 |
DisclosureSEC source: 0000899243-20-012046 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,528,750 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $28.62 to $29.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5 and 6. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| May 01, 2020 Filed May 5, 2020 10:13 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 300 | $29.87 | $8,960.01 |
DisclosureSEC source: 0000899243-20-011988 · doc4.xml · nonDerivative · entry 2 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,142 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F3 · price: Represents the weighted average sale price of the shares sold from $29.82 to $29.93 per share. Read SEC document |
| May 01, 2020 Filed May 5, 2020 10:13 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 2,285 | $29.19 | $66,693.44 |
DisclosureSEC source: 0000899243-20-011988 · doc4.xml · nonDerivative · entry 1 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,442 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $28.76 to $29.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:05 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-011523 · doc4.xml · derivative · entry 3 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,000 Underlying: Common Stock · 2,000 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F3 · derivative.exercise_date: The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:05 UTC |
Turtle CameronSee Remarks
|
SaleCommon Stock | 2,000 | $32.01 | $64,027.60 |
DisclosureSEC source: 0000899243-20-011523 · doc4.xml · nonDerivative · entry 2 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,823 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $32.00 to $32.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:05 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionCommon Stock | 2,000 | $17.00 | $34,000.00 |
DisclosureSEC source: 0000899243-20-011523 · doc4.xml · nonDerivative · entry 1 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 12:22 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-010631 · doc4.xml · derivative · entry 3 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 8,000 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F3 · derivative.exercise_date: The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 12:22 UTC |
Turtle CameronSee Remarks
|
SaleCommon Stock | 8,000 | $27.04 | $216,357.60 |
DisclosureSEC source: 0000899243-20-010631 · doc4.xml · nonDerivative · entry 2 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,823 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $27.00 to $27.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 12:22 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionCommon Stock | 8,000 | $17.00 | $136,000.00 |
DisclosureSEC source: 0000899243-20-010631 · doc4.xml · nonDerivative · entry 1 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 20:05 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 1,805 | $25.48 | $45,983.10 |
DisclosureSEC source: 0000899243-20-010587 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,565,372 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $25.24 to $25.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 01:17 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 100 | $25.10 | $2,510.00 |
DisclosureSEC source: 0000899243-20-010359 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,567,177 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F2 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 01:17 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 200 | $25.09 | $5,018.00 |
DisclosureSEC source: 0000899243-20-010359 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,567,277 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F2 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 20:06 UTC |
HOMCY CHARLES JDirector · Chairman of Pharmaceuticals
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-010392 · doc4.xml · nonDerivative · entry 1 HOMCY CHARLES J · CIK 0001192591 · Director · Chairman of Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302,291 Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 20:10 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 15,778 | $25.04 | $395,103.21 |
DisclosureSEC source: 0000899243-20-010119 · doc4.xml · nonDerivative · entry 5 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,567,477 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F7 · price: Represents the weighted average sale price of the shares sold from $25.00 to $25.30 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:11 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 1,286 | $27.74 | $35,677.11 |
DisclosureSEC source: 0000899243-20-010120 · doc4.xml · nonDerivative · entry 3 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,316 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $27.50 to $28.18 per share. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:11 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 2,500 | $26.86 | $67,149.00 |
DisclosureSEC source: 0000899243-20-010120 · doc4.xml · nonDerivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,602 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F3 · price: Represents the weighted average sale price of the shares sold from $26.44 to $27.42 per share. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:11 UTC |
STEPHENSON BRIAN CSee Remarks
|
SaleCommon Stock | 3,414 | $26.01 | $88,783.46 |
DisclosureSEC source: 0000899243-20-010120 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,102 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $25.43 to $26.41 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:13 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 1,100 | $27.56 | $30,313.03 |
DisclosureSEC source: 0000899243-20-010122 · doc4.xml · nonDerivative · entry 3 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,727 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F3 · price: Represents the weighted average sale price of the shares sold from $27.18 to $28.11 per share. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:13 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 1,441 | $26.51 | $38,198.60 |
DisclosureSEC source: 0000899243-20-010122 · doc4.xml · nonDerivative · entry 2 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,827 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $26.15 to $27.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:13 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 44 | $25.40 | $1,117.60 |
DisclosureSEC source: 0000899243-20-010122 · doc4.xml · nonDerivative · entry 1 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,268 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:10 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 1,382 | $28.20 | $38,979.03 |
DisclosureSEC source: 0000899243-20-010119 · doc4.xml · nonDerivative · entry 4 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,583,255 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F6 · price: Represents the weighted average sale price of the shares sold from $28.01 to $28.47 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:10 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 12,976 | $27.45 | $356,252.19 |
DisclosureSEC source: 0000899243-20-010119 · doc4.xml · nonDerivative · entry 3 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,584,637 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F5 · price: Represents the weighted average sale price of the shares sold from $27.00 to $27.99 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:10 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 20,040 | $26.38 | $528,623.14 |
DisclosureSEC source: 0000899243-20-010119 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,597,613 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $26.00 to $26.94 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:10 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 27,719 | $25.52 | $707,508.07 |
DisclosureSEC source: 0000899243-20-010119 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,617,653 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $25.00 to $25.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5, 6 and 7. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 22:55 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 201 | $33.22 | $6,677.32 |
DisclosureSEC source: 0000899243-20-006988 · doc4.xml · nonDerivative · entry 6 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,645,372 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F8 · price: Represents the weighted average sale price of the shares sold from $33.16 to $33.32 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 22:55 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 12,090 | $32.60 | $394,104.98 |
DisclosureSEC source: 0000899243-20-006988 · doc4.xml · nonDerivative · entry 5 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,645,573 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F7 · price: Represents the weighted average sale price of the shares sold from $32.15 to $33.14 per share. F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 22:55 UTC |
Kumar NeilDirector · CEO and President
|
SaleCommon Stock | 7,756 | $31.76 | $246,365.46 |
DisclosureSEC source: 0000899243-20-006988 · doc4.xml · nonDerivative · entry 4 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,657,663 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 22, 2019. F6 · price: Represents the weighted average sale price of the shares sold from $31.15 to $32.14 per share F3 · ownership.nature: The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:06 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 1,400 | $32.89 | $46,047.12 |
DisclosureSEC source: 0000899243-20-006942 · doc4.xml · nonDerivative · entry 2 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,312 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F3 · price: Represents the weighted average sale price of the shares sold from $32.65 to $33.21 per share. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:06 UTC |
HENDERSON MICHAEL THOMASSee Remarks
|
SaleCommon Stock | 2,575 | $32.20 | $82,918.09 |
DisclosureSEC source: 0000899243-20-006942 · doc4.xml · nonDerivative · entry 1 HENDERSON MICHAEL THOMAS · CIK 0001779990 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,712 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $31.57 to $32.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:11 UTC |
STEPHENSON BRIAN CSee Remark
|
SaleCommon Stock | 290 | $33.31 | $9,659.99 |
DisclosureSEC source: 0000899243-20-006945 · doc4.xml · nonDerivative · entry 3 STEPHENSON BRIAN C · CIK 0001780030 · See Remark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,516 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F4 · price: Represents the weighted average sale price of the shares sold from $33.27 to $33.36 per share. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:11 UTC |
STEPHENSON BRIAN CSee Remark
|
SaleCommon Stock | 5,550 | $32.65 | $181,179.75 |
DisclosureSEC source: 0000899243-20-006945 · doc4.xml · nonDerivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,806 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F3 · price: Represents the weighted average sale price of the shares sold from $32.27 to $33.25 per share. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:11 UTC |
STEPHENSON BRIAN CSee Remark
|
SaleCommon Stock | 4,960 | $31.79 | $157,701.22 |
DisclosureSEC source: 0000899243-20-006945 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,356 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. F2 · price: Represents the weighted average sale price of the shares sold from $31.26 to $32.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.